Indian health groups welcome country's first compulsory licence

BMJ. 2012 Mar 16:344:e2132. doi: 10.1136/bmj.e2132.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents* / economics
  • Benzenesulfonates* / economics
  • Drug Costs
  • Drug Industry
  • Drugs, Generic*
  • Humans
  • India
  • Licensure
  • Niacinamide / analogs & derivatives
  • Patents as Topic*
  • Phenylurea Compounds
  • Pyridines* / economics
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Drugs, Generic
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib